Growth factors rescue embryonic dopamine neurons from programmed cell death

Experimental Neurology

Volumn 140, Issue 1, 1996, Pages 60-67

  Zawada, W Michael ^a   Kirschman, David L ^a   Cohen, J John ^a   Heidenreich, Kim A ^a   Freed, Curt R ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTARABINE; GROWTH FACTOR; SOMATOMEDIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; NERVE DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0030198581     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0115     Document Type: Article

References (48)

1. 1. ARENDS, M. J., AND WYLLIE, A. H. 1991. Apoptosis, mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32: 223-254.
2. 2. AYER-LE LIEVRE, C., STÅHLBOM, P.-A., AND SARA, V. R. 1991. Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development 111: 105-115.
3. 3. BECK, K. D., KNÜSEL, B., AND HEFTI, F. 1993. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52: 855-866.
4. 4. BECK, K. D., VALVERDE, J., ALEXI, T., POULSEN, K., MOFFAT, B., VANDLEN, R. A., ROSENTHAL, A., AND HEFTI, F. 1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339-341.
5. 5. BJÖRKLUND, A., SCHMIDT, R. H., AND STENEVI, U. 1980. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res. 212: 39-45.
6. 6. BRUNDIN, P., BARBIN, G., ISACSON, O., MALLAT, M., CHAMAK, B., PROCHIANTZ, A., GAGE, F. H., AND BJÖRKLUND, A. 1985. Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro. Neurosci. Lett. 61: 79-84.
7. 7. CHOI, H. K., WON, L., AND HELLER, A. 1993. Dopaminergic neurons grown in three-dimensional reaggregate culture for periods of up to one year. J. Neurosci. Methods 46: 233-244.
8. 8. COHEN, J. J. 1993. Apoptosis. Immunol. Today 14: 126-130.
9. 9. COTZIAS, G. C., VAN WOERT, M. H., AND SCHIFFER, L. M. 1967. Aromatic amino acids and modification of parkinsonism. N. Engl. J. Med. 276: 374-379.
10. 10. CUNNINGHAM, L. A., HANSEN, J. T., SHORT, M. P., AND BOHN, M. C. 1991. The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res. 561: 192-202.
11. 11. D'MELLO, S. R., GALLI, C., CIOTTI, T., AND CALISSANO, P. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 90: 10989-10993.
12. 12. DEMPSEY, E. C., MCMURTRY, I. F., AND O'BRIEN, R. F. 1991. Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am. J. Physiol. 260: L136-L145.
13. 13. DRAGO, J., MURPHY, M., CARROLL, S. M., HARVEY, R. P., AND BARTLETT, P. F. 1991. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 88: 2199-2203.
14. 14. EHRINGER, H., AND HORNYKIEWICZ, O. 1960. Verteilung von noradrenalin and dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin. Wochenschr. 38: 1236-1239.
15. 15. ENGELE, J., AND BOHN, M. C. 1991. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11: 3070-3078.
16. 16. FERRARI, G., MINOZZI, M.-C., TOFFANO, G., LEON, A., AND SKAPER, S. D. 1989. Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 133: 140-147.
17. 17. FREED, C. R., BREEZE, R. E., ROSENBERG, N. L., SCHNECK, S. A., WELLS, T. H., BARRETT, J. N., GRAFTON, S. T., HUANG, S. C., EIDELBERG, D., AND ROTTENBERG, D. A. 1990. Transplantation of human fetal dopamine cells for Parkinson's disease. Arch. Neurol. 47: 505-512.
18. 18. FREED, C. R., BREEZE, R. E., ROSENBERG, N. L., SCHNECK, S. A., KRIEK, E., Qi, J.-X., LONE, T., ZHANG, Y.-B., SNYDER, J. A., WELLS, T. H., RAMIG, L. O., THOMPSON, L., MAZZIOTTA, J. C., HUANG, S. C., GRAFTON, S. T., BROOKS, D., SAWLE, G., SCHROTER, G., AND ANSARI, A. A. 1992. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327: 1549-1555.
19. 19. FRÖDIN, M., AND GAMMELTOFT, S. 1994. Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation. Proc. Natl. Acad. Sci. USA 91: 1771-1775.
20. 20. HAIMOVITZ-FRIEDMAN, A., BALABAN, N., MCLOUGHLIN, M., EHLEITER, D., MICHAELI, J., VLODAVSKY, I., AND FUKS, Z. 1994. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54: 2591-2597.
21. +-induced degeneration. J. Neurosci. Res. 32: 190-201.
22. 22. HERREGODTS, P., AND MICHOTTE, Y. 1987. Combined ion-pair extraction and high-performance liquid chromatography for the determination of the biogenic amines and their major metabolites in single brain tissue samples. J. Chromatogr. 421: 51-60.
23. 23. HYMAN, C., HOFER, M., BARDE, Y-A., JUHASZ, M., YANCOPOULOS, G. D., SQUINTO, S. P., AND LINDSAY, R. M. 1991. BDNF is a neurotrophic factor for dopaminegic neurons of the substantia nigra. Nature 350: 230-232.
24. 24. KARENBERG, T. -A., FENN, A., SACHINIDIS, A., AND HOPPE, J. 1994. The differential activation of phoshatidylinositol-3 kinase and mitogen-activated protein kinases by PDGF and IGF-I might explain the synergistic effect of the two growth factors on the proliferation of AKR-2B fibroblasts. Exp. Cell Res. 213: 266-274.
25. 25. KNUSEL, B., MICHEL, P. P., SCHWABER, J. S., AND HEFTI, F. 1990. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10: 558-570.
26. 26. KORDOWER, J. H., FREEMAN, T. B., SNOW, B. J., VINGERHOETS, F. J. G., MUFSON, E. J., SANBERG, P. R., HAUSER, R. A., SMITH, D. A., NAUERT, G. M., PERL, D. P., AND OLANOW, C. W. 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332: 1118-1124.
27. 27. KUMMER, J. L., ZAWADA, W. M., FREED, C. R., AND HEIDENREICH, K. A. 1995. Insulin-like growth factor I (IGF-I) acts synergistically with basic fibroblast growth factor (bFGF) to upregulate IGF binding proteins (IGFBPs) in fetal rat mesencephalic cultures. Endocr. Soc. Prog. Abstr. 77: 515.
28. 28. LIN, L.-F. H., DOHERTY, D. H., LILE, J. D., BEKTESH, S., AND COLLINS, F. 1993. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
29. 29. LINDVALL, O., BRUNDIN, P., WIDNER, H., REHNCRONA, S., GUSTAVII, B., FRACKOWIAK, R., LEENDERS, K. L., SAWLE, G., ROTHWELL, J. C., MARSDEN, C. D., AND BJÖRKLUND, A. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247: 574-577.
30. 30. MACAYA, A., MUNELL, F., GUBITS, R. M., AND BURKE, R. E. 1994. Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci. USA 91: 8117-8121.
31. 31. MAHALIK, T. J., HAHN, W. E., CLAYTON, G. H., AND OWENS, G. P. 1994. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129: 27-36.
32. 32. MAYER, E., DUNNETT, S. B., AND FAWCETT, J. W. 1993. Mitogenic effect of fibroblast growth factor on embryonic ventral mesencephalic dopaminergic neurone precursors. Dev. Brain Res. 72: 253-258.
33. 33. MAYER, E., DUNNETT, S. B., PELLITTERI, R., AND FAWCETT, J. W. 1993. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. I. Effects in vitro. Neuroscience 56: 379-388.
34. +-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 599: 83-97.
35. 35. ROSE, D. W., SALTIEL, A. R., MAJUMDAR, M., DECKER, S. J., AND OLEFSKY, J. M. 1994. Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc. Natl. Acad. Sci. USA 91: 797-801.
36. 36. SHEMER, J., RAIZADA, M. K., MASTERS, B. A., OTA, A., AND LEROITH, D. 1987. Insulin-like growth factor I receptors in neuronal and glial cells. J. Biol. Chem. 262: 7693-7699.
37. 37. SPENCER, D. D., ROBBINS, R. J., NAFTOLIN, F., MAREK, K. L., VOLLMER, T., LERANTH, C., ROTH, R. H., PRICE, L. H., GJEDDE, A., BUNNEY, B. S., SASS, K. J., ELSWORTH, J. D., KIER, E. L., MAKUCH, R., HOFFER, P. B., AND REDMOND, D. E., JR. 1992. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327: 1541-1548.
38. 38. STEINBUSCH, H. W. M., VERMEULEN, R. J., AND TONNAER, J. A. D. M. 1990. Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamen: Preliminary observations. Prog. Brain Res. 82: 81-86.
39. 39. TAKAYAMA, H., RAY, J., RAYMON, H. K., BAIRD, A., HOGG, J., FISHER, L. J., AND GAGE, F. H. 1995. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med. 1: 53-58.
40. 40. TOMAC, A., LINDQVIST, E., LIN, L.-F. H., OGREN, S. O., YOUNG, D., HOFFER, B. J., AND OLSON, L. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339.
41. 41. VILLAUDY, J., DELBÉ, J., BLAT, C., DESAUTY, G., GOLDE, A., AND HAREL, L. 1991. An IGF binding protein is an inhibitor of FGF stimulation. J. Cell. Physiol. 149: 492-496.
42. 42. WALICKE, P. A., AND BAIRD, A. 1991. Internalization and processing of basic fibroblast growth factor by neurons and astrocytes. J. Neurosci. 11: 2249-2258.
43. 43. WEISE, B., JANET, T., AND GROTHE, C. 1993. Localization of bFGF and FGF-receptor in the developing nervous system of the embryonic and newborn rat. J. Neurosci. Res. 34: 442-453.
44. 44. WHYTE, M., AND EVAN, G. 1995. Apoptosis: The last cut is the deepest. Nature 376: 17-18.
45. 45. WIDNER, H., TETRUD, J., REHNCRONA, S., SNOW, B., BRUNDIN, P., GUSTAVII, B., BJÖRKLUND, A., LINDVALL, O., AND LANGSTON, J. W. 1992. Bilatral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327: 1556-1563.
46. 46. WILSON, K. P., BLACK, J.-A. F., THOMSON, J. A., KIM, E. E., GRIFFITH, J. P., NAVIA, M. A., MURCKO, M. A., CHAMBERS, S. P., ALDAPE, R. A., RAYBUCK, S. A., AND LIVINGSTON, D. J. 1994. Structure and mechanism of interleukin-1β converting enzyme. Nature 370: 270-275.
47. 47. XIA, Z., DICKENS, M., RAINGEAUD, J., DAVIS, R. J., AND GREENBERG, M. E. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
48. 48. YAYON, A., KLAGSBRUN, M., ESKO, J. D., LEDER, P., AND ORNITZ, D. M. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.